258 related articles for article (PubMed ID: 27400689)
1. Granisetron Transdermal System for Treatment of Symptoms of Gastroparesis: A Prescription Registry Study.
Midani D; Parkman HP
J Neurogastroenterol Motil; 2016 Oct; 22(4):650-655. PubMed ID: 27400689
[TBL] [Abstract][Full Text] [Related]
2. Granisetron transdermal system improves refractory nausea and vomiting in gastroparesis.
Simmons K; Parkman HP
Dig Dis Sci; 2014 Jun; 59(6):1231-4. PubMed ID: 24615549
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic response to domperidone in gastroparesis: A prospective study using the GCSI-daily diary.
Heckert J; Parkman HP
Neurogastroenterol Motil; 2018 Jan; 30(1):. PubMed ID: 29110425
[TBL] [Abstract][Full Text] [Related]
4. Evaluating symptom outcomes in gastroparesis clinical trials: validity and responsiveness of the Gastroparesis Cardinal Symptom Index-Daily Diary (GCSI-DD).
Revicki DA; Camilleri M; Kuo B; Szarka LA; McCormack J; Parkman HP
Neurogastroenterol Motil; 2012 May; 24(5):456-63, e215-6. PubMed ID: 22284754
[TBL] [Abstract][Full Text] [Related]
5. Domperidone to Treat Symptoms of Gastroparesis: Benefits and Side Effects from a Large Single-Center Cohort.
Schey R; Saadi M; Midani D; Roberts AC; Parupalli R; Parkman HP
Dig Dis Sci; 2016 Dec; 61(12):3545-3551. PubMed ID: 27530760
[TBL] [Abstract][Full Text] [Related]
6. Gastric Electric Stimulation for Refractory Gastroparesis: A Prospective Analysis of 151 Patients at a Single Center.
Heckert J; Sankineni A; Hughes WB; Harbison S; Parkman H
Dig Dis Sci; 2016 Jan; 61(1):168-75. PubMed ID: 26280084
[TBL] [Abstract][Full Text] [Related]
7. Meal Eating Characteristics of Patients with Gastroparesis.
Hagopian GG; Johnson KP; Shahsavari D; Parkman HP
Dig Dis Sci; 2022 Aug; 67(8):3872-3880. PubMed ID: 34324088
[TBL] [Abstract][Full Text] [Related]
8. Combination of symptoms, syndrome and disease: treatment of refractory diabetic gastroparesis.
Li JL; Li M; Pang B; Zhou Q; Tian JX; Liu HX; Zhao XY; Tong XL
World J Gastroenterol; 2014 Jul; 20(26):8674-80. PubMed ID: 25024625
[TBL] [Abstract][Full Text] [Related]
9. Mirtazapine for symptom control in refractory gastroparesis.
Malamood M; Roberts A; Kataria R; Parkman HP; Schey R
Drug Des Devel Ther; 2017; 11():1035-1041. PubMed ID: 28408802
[TBL] [Abstract][Full Text] [Related]
10. Surgical Treatment for Refractory Gastroparesis: Stimulator, Pyloric Surgery, or Both?
Zoll B; Jehangir A; Edwards MA; Petrov R; Hughes W; Malik Z; Parkman HP
J Gastrointest Surg; 2020 Oct; 24(10):2204-2211. PubMed ID: 31512100
[TBL] [Abstract][Full Text] [Related]
11. Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity.
Parkman HP; Yates K; Hasler WL; Nguyen L; Pasricha PJ; Snape WJ; Farrugia G; Koch KL; Abell TL; McCallum RW; Lee L; Unalp-Arida A; Tonascia J; Hamilton F;
Gastroenterology; 2011 Jan; 140(1):101-15. PubMed ID: 20965184
[TBL] [Abstract][Full Text] [Related]
12. Symptoms of gastroparesis: use of the gastroparesis cardinal symptom index in symptomatic patients referred for gastric emptying scintigraphy.
Cassilly DW; Wang YR; Friedenberg FK; Nelson DB; Maurer AH; Parkman HP
Digestion; 2008; 78(2-3):144-51. PubMed ID: 19033686
[TBL] [Abstract][Full Text] [Related]
13. Gastric electrical stimulation: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(16):1-79. PubMed ID: 23074486
[TBL] [Abstract][Full Text] [Related]
14. Pyloric sphincter characteristics using EndoFLIP
Saadi M; Yu D; Malik Z; Parkman HP; Schey R
Rev Gastroenterol Mex (Engl Ed); 2018; 83(4):375-384. PubMed ID: 29709494
[TBL] [Abstract][Full Text] [Related]
15. Early satiety and postprandial fullness in gastroparesis correlate with gastroparesis severity, gastric emptying, and water load testing.
Parkman HP; Hallinan EK; Hasler WL; Farrugia G; Koch KL; Nguyen L; Snape WJ; Abell TL; McCallum RW; Sarosiek I; Pasricha PJ; Clarke J; Miriel L; Tonascia J; Hamilton F;
Neurogastroenterol Motil; 2017 Apr; 29(4):. PubMed ID: 27781342
[TBL] [Abstract][Full Text] [Related]
16. Symptom variability throughout the day in patients with gastroparesis.
Shahsavari D; Yu D; Jehangir A; Lu X; Zoll B; Parkman HP
Neurogastroenterol Motil; 2020 Feb; 32(2):e13740. PubMed ID: 31782211
[TBL] [Abstract][Full Text] [Related]
17. Randomized clinical trial: a controlled pilot trial of the 5-HT4 receptor agonist revexepride in patients with symptoms suggestive of gastroparesis.
Tack J; Rotondo A; Meulemans A; Thielemans L; Cools M
Neurogastroenterol Motil; 2016 Apr; 28(4):487-97. PubMed ID: 27010235
[TBL] [Abstract][Full Text] [Related]
18. Hair Loss in Patients with Gastroparesis: A Sign of Nutritional Deficiency in Gastroparesis?
Silver PJ; Coles MJ; Heath CR; Parkman HP
Dig Dis Sci; 2023 Apr; 68(4):1397-1402. PubMed ID: 36853546
[TBL] [Abstract][Full Text] [Related]
19. Predictive factors for clinical improvement with Enterra gastric electric stimulation treatment for refractory gastroparesis.
Maranki JL; Lytes V; Meilahn JE; Harbison S; Friedenberg FK; Fisher RS; Parkman HP
Dig Dis Sci; 2008 Aug; 53(8):2072-8. PubMed ID: 18080765
[TBL] [Abstract][Full Text] [Related]
20. Relationships among intragastric meal distribution during gastric emptying scintigraphy, water consumption during water load satiety testing, and symptoms of gastroparesis.
Parkman HP; Wilson LA; Silver P; Maurer AH; Sarosiek I; Bulat RS; Kuo B; Grover M; Farrugia G; Chumpitazi BP; Shulman RJ; Malik Z; Miriel LA; Tonascia J; Hamilton F; Abell TL; Pasricha PJ; McCallum RW; Koch KL;
Am J Physiol Gastrointest Liver Physiol; 2023 Nov; 325(5):G407-G417. PubMed ID: 37552206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
